Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Revenue | 40.02 | 36.15 | 30.06 | 22.48 |
Total Revenue | 40.02 | 36.15 | 30.06 | 22.48 |
Costof Revenue Total | 28.92 | 26.25 | 25.85 | 21.14 |
Gross Profit | 11.10 | 9.90 | 4.21 | 1.34 |
Selling/ General/ Admin Expenses Total | 0.87 | 0.55 | 0.48 | 0.48 |
Depreciation/ Amortization | 0.25 | 0.16 | 0.17 | 0.12 |
Unusual Expense( Income) | 0.00 | 0.90 | - | - |
Other Operating Expenses Total | 1.65 | 1.29 | 0.75 | 0.69 |
Total Operating Expense | 31.69 | 29.16 | 27.25 | 22.43 |
Operating Income | 8.33 | 6.99 | 2.81 | 0.06 |
Interest Inc( Exp) Net- Non- Op Total | -0.47 | -0.14 | -0.05 | 0.00 |
Other Net | 0.00 | 0.00 | 0.00 | 0.01 |
Net Income Before Taxes | 8.28 | 6.98 | 2.81 | 0.06 |
Provisionfor Income Taxes | 2.08 | 1.78 | 0.75 | 0.02 |
Net Income After Taxes | 6.20 | 5.21 | 2.06 | 0.04 |
Net Income Before Extra Items | 6.20 | 5.21 | 2.06 | 0.04 |
Net Income | 6.20 | 5.21 | 2.06 | 0.04 |
Income Availableto Com Excl Extra Ord | 6.20 | 5.21 | 2.06 | 0.04 |
Income Availableto Com Incl Extra Ord | 6.20 | 5.21 | 2.06 | 0.04 |
Diluted Net Income | 6.20 | 5.21 | 2.06 | 0.04 |
Diluted Weighted Average Shares | 1.16 | 1.16 | 1.16 | 1.16 |
Diluted EPS Excluding Extra Ord Items | 5.36 | 4.50 | 1.78 | 0.04 |
Diluted Normalized EPS | 5.36 | 5.08 | 1.78 | 0.04 |
DPS- Common Stock Primary Issue | - | - | 0.00 | 0.00 |
Total Adjustmentsto Net Income | - | - | - | 0.00 |
Shelter Pharma Dividend Shelter Pharma Bonus Shelter Pharma News Shelter Pharma AGM Shelter Pharma Rights Shelter Pharma Splits Shelter Pharma Board Meetings Shelter Pharma Key Metrics Shelter Pharma Shareholdings Shelter Pharma Balance Sheet Shelter Pharma Cashflow Shelter Pharma Q1 Results Shelter Pharma Q2 Results Shelter Pharma Q3 Results Shelter Pharma Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks